Abivax Average Payables vs Pb Ratio Analysis

ABVX Stock

126.48 7.38 6.20%

Abivax SA financial indicator trend analysis is way more than just evaluating Abivax SA American prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Abivax SA American is a good investment. Please check the relationship between Abivax SA Average Payables and its Pb Ratio accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abivax SA American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

Average Payables vs Pb Ratio

Average Payables vs Pb Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Abivax SA American Average Payables account and Pb Ratio. At this time, the significance of the direction appears to have no relationship.

The correlation between Abivax SA's Average Payables and Pb Ratio is 0.02. Overlapping area represents the amount of variation of Average Payables that can explain the historical movement of Pb Ratio in the same time period over historical financial statements of Abivax SA American, assuming nothing else is changed. The correlation between historical values of Abivax SA's Average Payables and Pb Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Average Payables of Abivax SA American are associated (or correlated) with its Pb Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Pb Ratio has no effect on the direction of Average Payables i.e., Abivax SA's Average Payables and Pb Ratio go up and down completely randomly.

Correlation Coefficient

0.02

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Pb Ratio

Most indicators from Abivax SA's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Abivax SA American current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abivax SA American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services.

At this time, Abivax SA's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to rise to 3.69 in 2026, whereas Issuance Of Capital Stock is likely to drop slightly above 474.1 K in 2026.

	2023	2024	2025	2026 (projected)
Interest Expense	13.8M	4.2M	4.8M	3.0M
Depreciation And Amortization	707K	1.1M	1.3M	1.3M

Interest Expense Depreciation And Amortization

Abivax SA fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Retained Earnings	Short Term Debt	Intangible Assets	Common Stock	Other Assets
Total Assets		0.84	0.35	0.92	0.67	0.74	-0.85	0.95	1.0	0.83	0.72	1.0	0.95	-0.82	0.87	-0.02	0.82	0.85	0.94	0.9	1.0	-0.88	0.82	0.84	0.95	-0.08
Short Long Term Debt Total	0.84		0.22	0.97	0.17	0.92	-0.43	0.96	0.84	0.73	0.57	0.81	0.93	-0.8	0.96	-0.36	0.99	0.94	0.93	0.99	0.84	-0.95	0.94	0.86	0.94	0.05
Other Current Liab	0.35	0.22		0.31	0.33	0.23	-0.38	0.26	0.35	0.4	0.37	0.36	0.19	-0.36	0.22	0.08	0.17	0.2	0.22	0.25	0.34	-0.17	0.07	0.34	0.27	0.27
Total Current Liabilities	0.92	0.97	0.31		0.36	0.92	-0.6	0.98	0.92	0.84	0.71	0.9	0.96	-0.9	0.96	-0.24	0.92	0.94	0.97	0.99	0.92	-0.97	0.96	0.95	0.99	0.12
Total Stockholder Equity	0.67	0.17	0.33	0.36		0.09	-0.95	0.42	0.68	0.49	0.5	0.71	0.47	-0.36	0.28	0.47	0.16	0.27	0.46	0.28	0.68	-0.31	0.21	0.34	0.43	-0.26
Property Plant And Equipment Net	0.74	0.92	0.23	0.92	0.09		-0.32	0.86	0.73	0.68	0.54	0.71	0.82	-0.85	0.95	-0.27	0.85	0.95	0.9	0.91	0.74	-0.93	0.94	0.92	0.91	0.17
Net Debt	-0.85	-0.43	-0.38	-0.6	-0.95	-0.32		-0.65	-0.85	-0.66	-0.67	-0.87	-0.68	0.58	-0.51	-0.23	-0.42	-0.49	-0.66	-0.53	-0.85	0.55	-0.45	-0.56	-0.65	0.18
Accounts Payable	0.95	0.96	0.26	0.98	0.42	0.86	-0.65		0.95	0.81	0.67	0.93	0.98	-0.85	0.95	-0.22	0.94	0.93	0.97	0.99	0.95	-0.96	0.92	0.89	0.98	-0.01
Cash	1.0	0.84	0.35	0.92	0.68	0.73	-0.85	0.95		0.82	0.72	1.0	0.94	-0.81	0.87	-0.06	0.82	0.84	0.93	0.89	1.0	-0.88	0.81	0.83	0.94	-0.09
Non Current Assets Total	0.83	0.73	0.4	0.84	0.49	0.68	-0.66	0.81	0.82		0.89	0.81	0.83	-0.88	0.7	-0.14	0.67	0.65	0.77	0.78	0.82	-0.73	0.79	0.87	0.79	0.42
Non Currrent Assets Other	0.72	0.57	0.37	0.71	0.5	0.54	-0.67	0.67	0.72	0.89		0.72	0.73	-0.86	0.54	-0.1	0.49	0.49	0.64	0.63	0.71	-0.64	0.68	0.79	0.65	0.51
Cash And Short Term Investments	1.0	0.81	0.36	0.9	0.71	0.71	-0.87	0.93	1.0	0.81	0.72		0.93	-0.8	0.85	0.01	0.79	0.83	0.93	0.87	1.0	-0.86	0.79	0.82	0.93	-0.1
Net Receivables	0.95	0.93	0.19	0.96	0.47	0.82	-0.68	0.98	0.94	0.83	0.73	0.93		-0.84	0.91	-0.14	0.91	0.89	0.96	0.96	0.95	-0.94	0.92	0.88	0.96	0.02
Good Will	-0.82	-0.8	-0.36	-0.9	-0.36	-0.85	0.58	-0.85	-0.81	-0.88	-0.86	-0.8	-0.84		-0.82	0.16	-0.72	-0.79	-0.86	-0.84	-0.81	0.89	-0.89	-0.97	-0.87	-0.38
Common Stock Shares Outstanding	0.87	0.96	0.22	0.96	0.28	0.95	-0.51	0.95	0.87	0.7	0.54	0.85	0.91	-0.82		-0.24	0.93	1.0	0.97	0.97	0.87	-0.97	0.93	0.89	0.98	-0.06
Short Term Investments	-0.02	-0.36	0.08	-0.24	0.47	-0.27	-0.23	-0.22	-0.06	-0.14	-0.1	0.01	-0.14	0.16	-0.24		-0.38	-0.23	-0.1	-0.3	-0.02	0.2	-0.3	-0.2	-0.17	-0.18
Non Current Liabilities Total	0.82	0.99	0.17	0.92	0.16	0.85	-0.42	0.94	0.82	0.67	0.49	0.79	0.91	-0.72	0.93	-0.38		0.91	0.89	0.98	0.82	-0.91	0.88	0.77	0.91	-0.05
Other Current Assets	0.85	0.94	0.2	0.94	0.27	0.95	-0.49	0.93	0.84	0.65	0.49	0.83	0.89	-0.79	1.0	-0.23	0.91		0.97	0.95	0.85	-0.96	0.91	0.87	0.97	-0.11
Other Stockholder Equity	0.94	0.93	0.22	0.97	0.46	0.9	-0.66	0.97	0.93	0.77	0.64	0.93	0.96	-0.86	0.97	-0.1	0.89	0.97		0.95	0.94	-0.97	0.93	0.91	0.99	-0.05
Total Liab	0.9	0.99	0.25	0.99	0.28	0.91	-0.53	0.99	0.89	0.78	0.63	0.87	0.96	-0.84	0.97	-0.3	0.98	0.95	0.95		0.89	-0.96	0.94	0.89	0.97	0.05
Total Current Assets	1.0	0.84	0.34	0.92	0.68	0.74	-0.85	0.95	1.0	0.82	0.71	1.0	0.95	-0.81	0.87	-0.02	0.82	0.85	0.94	0.89		-0.88	0.82	0.83	0.94	-0.09
Retained Earnings	-0.88	-0.95	-0.17	-0.97	-0.31	-0.93	0.55	-0.96	-0.88	-0.73	-0.64	-0.86	-0.94	0.89	-0.97	0.2	-0.91	-0.96	-0.97	-0.96	-0.88		-0.96	-0.91	-0.97	-0.03
Short Term Debt	0.82	0.94	0.07	0.96	0.21	0.94	-0.45	0.92	0.81	0.79	0.68	0.79	0.92	-0.89	0.93	-0.3	0.88	0.91	0.93	0.94	0.82	-0.96		0.93	0.93	0.2
Intangible Assets	0.84	0.86	0.34	0.95	0.34	0.92	-0.56	0.89	0.83	0.87	0.79	0.82	0.88	-0.97	0.89	-0.2	0.77	0.87	0.91	0.89	0.83	-0.91	0.93		0.92	0.33
Common Stock	0.95	0.94	0.27	0.99	0.43	0.91	-0.65	0.98	0.94	0.79	0.65	0.93	0.96	-0.87	0.98	-0.17	0.91	0.97	0.99	0.97	0.94	-0.97	0.93	0.92		-0.03
Other Assets	-0.08	0.05	0.27	0.12	-0.26	0.17	0.18	-0.01	-0.09	0.42	0.51	-0.1	0.02	-0.38	-0.06	-0.18	-0.05	-0.11	-0.05	0.05	-0.09	-0.03	0.2	0.33	-0.03

Click cells to compare fundamentals

Abivax SA Account Relationship Matchups

Abivax SA fundamental ratios Accounts

	2021	2022	2023	2024	2025	2026 (projected)
Total Assets	109.2M	75.5M	327.1M	205.2M	236.0M	247.8M
Short Long Term Debt Total	51.7M	39.2M	58.0M	97.4M	112.0M	117.6M
Other Current Liab	3.2M	5.7M	7.2M	532K	611.8K	642.4K
Total Current Liabilities	32.3M	51.5M	88.1M	92.8M	106.8M	112.1M
Total Stockholder Equity	25.9M	7.2M	196.0M	40.6M	46.7M	53.7M
Property Plant And Equipment Net	93K	1.6M	877K	2.7M	3.1M	3.2M
Net Debt	(9.0M)	12.2M	(193.9M)	(46.9M)	(42.2M)	(40.1M)
Accounts Payable	18.6M	15.5M	47.2M	43.8M	50.4M	52.9M
Cash	60.7M	27.0M	251.9M	144.2M	165.9M	174.1M
Non Current Assets Total	35.2M	39.4M	41.1M	34.6M	39.7M	38.0M
Non Currrent Assets Other	2.7M	12.7M	15.1M	6.7M	7.8M	4.0M
Cash And Short Term Investments	60.7M	27.0M	261.0M	144.2M	165.9M	174.1M
Net Receivables	8.3M	8.3M	19.1M	15.7M	18.0M	18.9M
Common Stock Shares Outstanding	15.5M	19.1M	43.1M	63.0M	72.5M	76.1M
Liabilities And Stockholders Equity	110.4M	75.5M	327.1M	205.2M	236.0M	247.8M
Non Current Liabilities Total	51.0M	16.9M	42.9M	71.8M	82.6M	86.7M
Other Current Assets	721K	915K	5.9M	10.8M	12.4M	13.0M
Other Stockholder Equity	107.6M	150.5M	478.2M	478.9M	550.7M	578.3M
Total Liab	83.3M	68.4M	131.1M	164.6M	189.3M	198.8M
Total Current Assets	75.2M	36.2M	286.0M	170.7M	196.3M	206.1M
Retained Earnings	(81.8M)	(143.5M)	(282.9M)	(438.9M)	(395.0M)	(375.2M)
Short Term Debt	10.2M	30.0M	31.3M	43.8M	50.3M	52.9M
Intangible Assets	(647K)	6.6M	6.6M	6.6M	7.6M	8.0M
Common Stock	168K	223K	629K	633K	728.0K	764.3K
Inventory	1.1M	4M	12.2M	(5.9M)	(6.8M)	(6.4M)
Long Term Debt	53.4M	36.6M	44.7M	52.2M	60.0M	43.3M
Net Invested Capital	89.1M	54.8M	250.9M	135.6M	155.9M	114.0M
Property Plant And Equipment Gross	548K	841K	2.4M	4.0M	4.6M	4.9M
Short Long Term Debt	7K	9.5M	10.2M	42.8M	49.3M	51.7M
Capital Stock	168K	223K	629K	633K	728.0K	764.3K
Non Current Liabilities Other	5.7M	(1K)	3.3M	13.0M	15.0M	15.7M
Net Working Capital	54.0M	20.2M	215.9M	77.8M	89.5M	70.9M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc

Additional Tools for Abivax Stock Analysis

When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Abivax Average Payables vs Pb Ratio Analysis

Average Payables vs Pb Ratio

Average Payables vs Pb Ratio Correlation Analysis

Correlation Coefficient

Average Payables

Pb Ratio

Abivax SA fundamental ratios Correlations

Abivax SA Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Abivax SA fundamental ratios Accounts

Also Currently Popular

Additional Tools for Abivax Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments

Common Stock	- 0.97	Retained Earnings
Retained Earnings	- 0.97	Other Stockholder Equity
Retained Earnings	- 0.97	Common Stock Shares Outstanding
Intangible Assets	- 0.97	Good Will
Retained Earnings	- 0.97	Total Current Liabilities
Short Term Debt	- 0.96	Retained Earnings